Metraipolis › archive › dc_76c128d17dbf

Heparin formulation and thromboprophylaxis intensity in critically ill patients: results from the ESICM UNITE-COVID registry — Europe PMC PPR:PPR1241721

Source
Europe PMC
Original
https://europepmc.org/article/PPR/PPR1241721
DOI
10.21203/rs.3.rs-9734138/v1
License (as archived)
solo-consultazione
Archived
2026-10-07T19:48:54.891Z
SHA-256 of the archived text
6015399ecb2211b7ea488e368438fe0947014ee1df8699106a1c585df794baca
Stable URL of this page
https://metraipolis.com/documento/dc_76c128d17dbf

How to cite

Heparin formulation and thromboprophylaxis intensity in critically ill patients: results from the ESICM UNITE-COVID registry — Europe PMC PPR:PPR1241721 — Europe PMC, https://europepmc.org/article/PPR/PPR1241721 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_76c128d17dbf (Metraipolis archive dc_76c128d17dbf, sha256 6015399ecb2211b7ea488e368438fe0947014ee1df8699106a1c585df794baca)
BibTeX
@misc{dc76c128d17dbf,
  title = {Heparin formulation and thromboprophylaxis intensity in critically ill patients: results from the ESICM UNITE-COVID registry — Europe PMC PPR:PPR1241721},
  howpublished = {Europe PMC},
  url = {https://europepmc.org/article/PPR/PPR1241721},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_76c128d17dbf; sha256 6015399ecb2211b7ea488e368438fe0947014ee1df8699106a1c585df794baca},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/PPR/PPR1241721. Agents can read the archived copy with the MCP tool read_document.